Overview
Yu-kun Tsui practices practicing medicine in Tainan, Taiwan.
Tsui is highly rated in 1 condition, according to our data. Their clinical expertise encompasses Marginal Zone Lymphoma (MZL), Neurotoxicity Syndromes, Hypopituitarism, and Endovascular Embolization.
They are actively involved in clinical research, co-authoring 10 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Yu-kun Tsui
Is Yu-kun Tsui a top-rated expert for Endovascular Embolization?
MediFind is an objective health platform that identifies experts based on real-world data. Yu-kun Tsui is classified as an Advanced expert for Endovascular Embolization, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Yu-kun Tsui participate in research or clinical trials?
Yes. Yu-kun Tsui has published 10 articles and abstracts on conditions like Endovascular Embolization. You can view a list of Yu-kun Tsui's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Endovascular Embolization
- Experienced
- HypopituitarismTsui isExperienced. Learn about Hypopituitarism.
- Marginal Zone Lymphoma (MZL)
- Neurotoxicity SyndromesTsui isExperienced. Learn about Neurotoxicity Syndromes.